EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study

Xiaoli Lei iD, Xiaobei Liu iD, Yi Qu iD, Yanqin Huang iD

Brain and Behavior · 2025

DOI: 10.1002/brb3.70745 ↗

At a glance

Journal article in Brain and Behavior, 2025. Written by Xiaoli Lei and 3 co-authors. Institution: The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China. Major MEDLINE topics: Polycystic Ovary Syndrome, Metabolome. Cited 1 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Traditional Chinese Medicine Education Letter, Taishan Scholar Foundation of Shandong Province.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Evidence concerning the causal effects of blood metabolites on polycystic ovary syndrome (PCOS) risk remains scarce. A two‐sample Mendelian randomization (MR) analysis was performed among individuals of European ancestry to establish a causal relationship between plasma metabolites and the risk of PCOS.

Objective

To determine causal associations between 1400 blood metabolites and PCOS.

Methods

Utilizing data from a GWAS, which encompasses over 1400 blood metabolites, bidirectional MR was employed to explore the potential causal associations between PCOS and these metabolites. Causal inference methods included inverse variance weighting, MR‐Egger regression, weighted median, weighted mode, and simple mode approaches. Sensitivity analyses were performed to validate the robustness of the results. Reverse MR analyzed 1400 blood metabolites as outcomes and PCOS as the exposure.

Results

Fifteen plasma metabolites, including methionine sulfoxide, N‐acetylserine, and glycine, exhibited positive causal effects on PCOS risk. In contrast, 13 metabolites, including threonate, 7‐methylguanine, and theophylline, demonstrated protective effects. Leave‐one‐out analysis confirmed the stability of the results, with no influential instrumental variables, and eliminated the impacts of heterogeneity and horizontal pleiotropy. Reverse MR revealed no evidence of causal associations between PCOS and the metabolites.

Conclusion

Thirteen plasma metabolites were identified as protective factors for PCOS. Targeted modulation of these metabolites may improve metabolic dysfunction in patients, alleviating symptoms and enhancing quality of life. Further exploration of metabolite dynamics could advance mechanistic insights into PCOS pathogenesis and inform therapeutic development.

Subjects

MeSH terms (MEDLINE)

Polycystic Ovary SyndromeMetabolomeHumansFemaleMendelian Randomization AnalysisGenome-Wide Association StudyAdultPolymorphism, Single Nucleotide

Author keywords

1400 plasma metabolitesMendelian randomizationcausalitypolycystic ovary syndrome

Authors and institutions

  • The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of Reproductive Genetics, Taian Central Hospital, Taian, China.
  • Department of Endocrinology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

ORCID profiles: Xiaoli Lei, Xiaobei Liu, Yi Qu, Yanqin Huang

Funding

  • National Traditional Chinese Medicine Education Letter
  • Taishan Scholar Foundation of Shandong Province

Cite

APA

Lei, X., Liu, X., Qu, Y., & Huang, Y. (2025). Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study. Brain and Behavior. https://doi.org/10.1002/brb3.70745

Vancouver

Lei X, Liu X, Qu Y, Huang Y. Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study. Brain and Behavior. 2025. doi:10.1002/brb3.70745

BibTeX
@article{Lei2025,
  author = {Lei, Xiaoli and Liu, Xiaobei and Qu, Yi and Huang, Yanqin},
  title = {Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70745}
}
Start for free →